Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cytosorbents Cor
(NQ:
CTSO
)
0.9102
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cytosorbents Cor
< Previous
1
2
3
4
5
Next >
CytoSorbents Reports Second Quarter 2023 Financial and Operational Results
August 01, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents to Report Second Quarter 2023 Operating and Financial Results
July 26, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Appoints Alexander D’Amico as Chief Financial Officer
July 19, 2023
From
CytoSorbents
Via
GlobeNewswire
A Preview Of CytoSorbents's Earnings
May 01, 2023
Via
Benzinga
Looking Into CytoSorbents's Return On Capital Employed
March 13, 2023
Via
Benzinga
CytoSorbents Earnings Preview
March 08, 2023
Via
Benzinga
CytoSorbents's Return On Capital Employed Overview
November 21, 2022
Via
Benzinga
CytoSorbents And Humedics Announce Theranostic Collaboration in the Field of Liver Disease
July 11, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial
July 07, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents This Week to Host its Virtual Annual Stockholders Meeting and to Present at the Jefferies Healthcare Conference
June 05, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Reports First Quarter 2023 Results
May 02, 2023
Pivotal U.S. and Canada STAR-T Trial enrollment enters the last third of the study. Strong customer demand from Q4 2022 continued into Q1 2023, with current expectation of overall sales growth in 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents to Report First Quarter 2023 Operating and Financial Results
April 26, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled
April 20, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Announces Board Chairman Al W. Kraus To Retire
April 19, 2023
From
CytoSorbents
Via
GlobeNewswire
Landmark Publication Underscores Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic Hyperinflammation
March 29, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)
March 22, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Comments on Bank Exposure and Diversified Cash Position
March 14, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Reports Fourth Quarter and Full Year 2022 Results
March 09, 2023
From
CytoSorbents
Via
GlobeNewswire
New European “Guidelines for the Management of Severe Perioperative Bleeding” Consider Hemoadsorption for the First-Time
March 07, 2023
From
CytoSorbents
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
February 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 03, 2023
Via
Benzinga
Why Cytosorbents Shares Are Popping Off Thursday
December 29, 2022
Cytosorbents Corp (NASDAQ: CTSO) shares are trading higher by 15.55% to $1.38 Thursday afternoon after the company announced it received $5 million in non-dilutive debt financing from Bridge Bank and...
Via
Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
November 04, 2022
Gainers
Via
Benzinga
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
November 07, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 04, 2022
Gainers Incannex Healthcare (NASDAQ:IXHL) shares moved upwards by 30.7% to $5.19 during Friday's pre-market session. The market value of their outstanding shares is at $316.2 million.
Via
Benzinga
Why Starbucks Shares Are Trading Higher; Here Are 43 Stocks Moving Premarket
November 04, 2022
Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares rose 67.7% to $5.10 in pre-market trading after jumping 24% on Thursday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
November 04, 2022
We're starting off the final day of trading this week with a look at the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 02, 2022
Gainers Monopar Therapeutics (NASDAQ:MNPR) shares increased by 53.0% to $4.09 during Wednesday's pre-market session. The company's market cap stands at $52.0 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 18, 2022
It's time for another look at the biggest pre-market stock movers as we check out what's happening with shares on Tuesday morning!
Via
InvestorPlace
Why fuboTV Shares Are Trading Higher By 11%; Here Are 22 Stocks Moving Premarket
October 18, 2022
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 78.1% to $0.0787 in pre-market trading after gaining 4% on Monday.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.